These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7139670)

  • 21. [Hepatitis B antigen in patients undergoing gastroscopy (author's transl)].
    Dittrich H; Atefie K
    Wien Klin Wochenschr; 1981 Jan; 93(2):60-3. PubMed ID: 7245772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis B virus infection in the absence of serological markers or with atypical serological patterns].
    Moreno García M
    Rev Clin Esp; 1997 Apr; 197(4):248-58. PubMed ID: 9254401
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis B among Israeli diabetics].
    Hakim M; Kanter Y; Ben-Porath E; Barzilai D
    Harefuah; 1981 Sep; 101(5-6):99-102. PubMed ID: 7344994
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
    Gupta RC
    Clin Exp Immunol; 1982 Sep; 49(3):543-51. PubMed ID: 7172494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis B markers in Indochinese refugees.
    Chaudhary RK; Nicholls ES; Kennedy DA
    Can Med Assoc J; 1981 Dec; 125(11):1243-6. PubMed ID: 7332883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of the appearance and dynamics of immune complexes in patients with chronic hepatitis].
    Bozić M; Milosević-Jovcić N; Cvorić M; Nikolić V; Tosić Lj
    Srp Arh Celok Lek; 1983 Jul; 111(7):889-903. PubMed ID: 6675191
    [No Abstract]   [Full Text] [Related]  

  • 27. [Circulating immunocomplexes in chronic hepatitis B].
    Stránský J; Votruba T; Vodák M; Zichová M; Sprincl L; Benda R
    Cas Lek Cesk; 1985 May; 124(18):560-5. PubMed ID: 4016846
    [No Abstract]   [Full Text] [Related]  

  • 28. Concurrence of hepatitis B surface antigen and antibody in acute and chronic hepatitis B cases.
    Ng KP; Saw TL
    Med J Malaysia; 1994 Jun; 49(2):117-21. PubMed ID: 8090089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple hepatitis B virus markers in dialysis patients.
    Acchiardo S; Cockrell S
    Trans Am Soc Artif Intern Organs; 1982; 28():308-11. PubMed ID: 7164253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis B markers in the personnel of clinical-diagnostic laboratories].
    Platonov SA; Orgel' MIa; Matoshko GV; Goroshnikov SB; Kutsenko IM
    Vrach Delo; 1981 Nov; (11):107-10. PubMed ID: 7342426
    [No Abstract]   [Full Text] [Related]  

  • 31. [The importance of HBsAg in differential diagnosis of virus hepatitis (author's transl)].
    Janout V; Sedlácek V; Chobot S; Walderová O; Sajdák E; Hofta J; Fierla T; Galetková A; Sekerová Z; Cechová D; Bindas B
    Cesk Epidemiol Mikrobiol Imunol; 1980 May; 29(3):151-9. PubMed ID: 6446412
    [No Abstract]   [Full Text] [Related]  

  • 32. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antigenic relationships between hepatitis type B and primary carcinoma of the liver].
    Zhang FS
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Feb; 3(1):49-52. PubMed ID: 6821028
    [No Abstract]   [Full Text] [Related]  

  • 34. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of immune-complex nephritis associated with hepatitis B surface antigen excess.
    Raz E; Michaeli J; Brezis M; Popovtzer MM; Gazitt Y; Shouval D
    Am J Nephrol; 1989; 9(2):162-6. PubMed ID: 2662773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated antibody to hepatitis B core antigen in individuals infected with HIV-1.
    Hung CC; Hsiao CF
    Clin Infect Dis; 2003 Nov; 37(9):1275-6;; author reply 1277. PubMed ID: 14557978
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors.
    Neriishi K; Akiba S; Amano T; Ogino T; Kodama K
    Radiat Res; 1995 Nov; 144(2):215-21. PubMed ID: 7480648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.
    Neau D; Winnock M; Galpérine T; Jouvencel AC; Castéra L; Legrand E; Tranchant E; Balestre E; Lacoste D; Ragnaud JM; Dupon M; Lafon ME; Dabis F;
    HIV Med; 2004 May; 5(3):171-3. PubMed ID: 15139983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B surface antigen and antibody prevalence (a survey at the College of Dentistry, University of Saskatchewan).
    Komiyama K; Epstein JB; Trew JA; Ross AS; Singer DL
    J Can Dent Assoc; 1981 Jan; 47(1):40-5. PubMed ID: 7004604
    [No Abstract]   [Full Text] [Related]  

  • 40. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.